13
Views
66
CrossRef citations to date
0
Altmetric
Transcriptional Regulation

STAT5 and Oct-1 Form a Stable Complex That Modulates Cyclin D1 Expression

, , , &
Pages 8934-8945 | Received 10 Feb 2003, Accepted 10 Sep 2003, Published online: 27 Mar 2023
 

Abstract

Signal transducer and activator of transcription 5 (STAT5) is activated by numerous cytokines that control blood cell development. STAT5 was also shown to actively participate in leukemogenesis. Among the target genes involved in cell growth, STAT5 had been shown to activate cyclin D1 gene expression. We now show that thrombopoietin-dependent activation of the cyclin D1 promoter depends on the integrity of a new bipartite proximal element that specifically binds STAT5A and -B transcription factors. We demonstrate that the stable recruitment of STAT5 to this element in vitro requires the integrity of an adjacent octamer element that constitutively binds the ubiquitous POU homeodomain protein Oct-1. We observe that cytokine-activated STAT5 and Oct-1 form a unique complex with the cyclin D1 promoter sequence. We find that STAT5 interacts with Oct-1 in vivo, following activation by different cytokines in various cellular contexts. This interaction involves a small motif in the carboxy-terminal region of STAT5 which, remarkably, is similar to an Oct-1 POU-interacting motif present in two well-known partners of Oct-1, namely, OBF-1/Bob and SNAP190. Our data offer new insights into the transcriptional regulation of the key cell cycle regulator cyclin D1 and emphasize the active roles of both STAT5 and Oct-1 in this process.

ACKNOWLEDGMENTS

Fabrice Gouilleux, Itaru Matsumura, and Lothar Henninghausen are gratefully acknowledged for kind gifts of plasmids and antibodies and for helpful discussions. We thank Claire Francastel, Sylvie Gisselbrecht, Vincent Mignotte, and Paul-Henri Romeo for reading the manuscript and providing valuable comments and Frank Letourneur and Nicolas Lebrun for DNA sequencing.

This work was supported by a grant from the Ligue Nationale Contre le Cancer. S.C. is the recipient of a fellowship from the Ligue Contre le Cancer.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.